Evaluation of cell viability of formulated fluconazole nanoemulgel by cytotoxicity analysis

Authors

  • Narang RS Department of Oral and Maxillofacial Pathology, Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar, Punjab, India Author
  • Srivastava S Department of Oral and Maxillofacial Pathology, Jaipur Dental College, Jaipur, Rajasthan, India. Author
  • Ali J Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New- Delhi, India Author
  • Baboota S Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New- Delhi, India Author
  • Singh B Department of Oral Medicine and Radiology, Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar, Punjab, India. Author
  • Kahlon SS Department of Orthodontics and Maxillofacial Orthopaedics, Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar, Punjab, India. Author
  • Dang S Department of Biotechnology, Jaypee Institute of Information Technology, Noida., India Author
  • Narang JK Department of Pharmaceutics, Khalsa College of Pharmacy, Amritsar, Punjab, India Author

DOI:

https://doi.org/10.61841/yr7p7j08

Keywords:

Cytotoxicity, Fluconazole nanoemulgel, Candidiasis

Abstract

Oral Candidiasis, also known as oral thrush among other names, is candidiasis that occurs in the oral cavity. Candida albicans is the most common species responsible for the disease. Fluconazole has a broad spectrum of activity and is currently the drug of choice for controlling oropharyngeal candidiasis, especially in patients suffering from AIDS. The aim of the present study was to evaluate the in vitro cytotoxicity and cell viability of fluconazole nanoemulgel formulated for the treatment of oral candidiasis. In vitro Vero cell line-based cytotoxicity analysis was performed using the MTT assay. It was observed that fluconazole-loaded nanoemulgel (FCZNE) showed dose-dependent cytotoxicity for the entire concentration range. Fluconazole-loaded nanoemulgel (FCZ-NE) exhibited cell viability of 100% to 76% for a concentration range of 2xCmax to 20xCmax, whereas fluconazole gel (FCZ) exhibited cell viability of 99% to 67% for the same concentration range. The results suggested that prepared fluconazole-loaded nanoemulgel (FCZ-NE) exhibited good cell viability in vitro, thus establishing its safety profile. 

Downloads

Download data is not yet available.

References

1. Hsu, J.L., Ruoss, S.J., Bower, N.D., Lin, M., Holodniy, M., Stevens, D.A., “Diagnosing invasive fungal disease in critically ill patients," Crit Rev Microbiology, 37 (2011), p. 277-312.

2. Baron, S., Medical Microbiology, 4th edition. (2012), Galveston (TX): University of Texas Medical Branch at Galveston.

3. Abu-Elteen, K.H., Abu-Alteen, R.M., “The prevalence of candida albicans populations in the mouths of complete denture wearers," New Microbiol, 21, (1998), p. 41–48.

4. Patton, L.L., Bonito, A.J., Shugars, D.A., “A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients," Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 92 (2001), p. 170–179.

5. Pienaar, E.D., Young, T., Holmes, H., “Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children," Cochrane Database Syst Rev, 9, (2013), CD003940.

6. Salerno, C., Carlucci, A.M., Bregni, C., “Study of in Vitro Drug Release and Percutaneous Absorption of Fluconazole from Topical Dosage Forms," AAPS PharmSciTech, 11(2), (2010), p. 986-993.

7. Vincent-Ballereau, F.N., Patey, O.N., Lafaix, C., “Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immunodeficiency virus infections," Pharm. Weekbl. Sci, 13, (1991), p. 45-57.

8. Noble, S.L., Forbes, R.C., Stamm, P.L., "Diagnosis and Management of Common Tinea Infections," 58(1), (1998), p. 163-174.

9. Serrano, I.O., Oliu, G.O., and Bellosa, O.M., Nanoemulsion-based delivery systems to improve functionality of lipophilic components," Front Nutr., 1 (2014), p. 24.

10. Sinha, M., Balamurgan, K., Ganesh, N., “Preparation and characterization of nanoemulsion based on papaya seed oil," Vivo Scientia, 4(2), (2015), p. 72-76.

11. Thakur, A., Walia, M.K., Kumar, S.L., "Nanoemulsion in enhancement of bioavailability of poorly soluble drugs: a review," Pharmacophore, 4(1), (2013), pp. 15-25.

12. Lee, M., Maibach, H.I. (2006), “ Deep percutaneous penetration into muscles and joints”, Journal of Pharmaceutical Science, 95(7), p. 1405-1413

13. Nigam k, Gabrania R, Dang S. Nano-emulsion from Capsaicin: “Formulation and Characterization.” Materials Today: Proceedings 18 (2019), pp. 869–878.

14. Shreaz, S., Bhatia, R., Khan, N., Muralidhar, S., Basir, S.F., Manzoor, N., and Khan, L.A.,. “Spice oil cinnamaldehyde exhibits potent anticandidal activity against fluconazole-resistant clinical isolates." Fitoterapia, 82(7), (2011), pp. 1012-1020.

15. Mohammed, N., Rejinold, N.S., Mangalathillam, S., Biswas, R., Nair, S.V., and Jayakumar, R. "Fluconazole-loaded chitin nanogels as a topical ocular drug delivery agent for corneal fungal infections." Journal of Biomedical Nanotechnology, 9(9), (2013.), pp. 1521-1531.

16. Misik J, Vodakova E, Pavlikova. R, Cabal. J, Novotny. L, Kuca, K.K. “Acute toxicity of surfactants and detergent-based decontaminants in mice and rats." Military Medical Science Letters 81 (2012), pp. 171-176.

17. Garay J., Julio C., Gergeres D., Young A., Lim D.V., Turos E., “Physical properties and biological activity of poly(butyl acrylate-styrene) nanoparticle emulsions prepared with conventional and polymerizable surfactants." Nanomedicine: Nanotechnology, Biology, and Medicine 5, no. 4 (2009), pp. 443–451.

Downloads

Published

30.04.2020

Issue

Vol. 24 No. 2 (2020): 24 (2) 2020

Section

Articles

License

Copyright (c) 2020 AUTHOR

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

RS, N., S, S., J, A., S, B., B, S., SS, K., S, D., & JK , N. (2020). Evaluation of cell viability of formulated fluconazole nanoemulgel by cytotoxicity analysis. International Journal of Psychosocial Rehabilitation, 24(2), 6213-6219. https://doi.org/10.61841/yr7p7j08